GelSana Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort
—One of 65 startups chosen from nearly 1,500 global applicants — Selected to participate in the world’s leading medtech accelerator
GelSana Therapeutics, an Innosphere Client Company focused on commercializing novel polymers for wound healing, announced today that it has been selected to join the MedTech Innovator 2025 Accelerator Cohort. GelSana is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program.
MedTech Innovator (MTI) is the world’s largest accelerator for medical technology startups. The highly competitive four-month program provides participants with world-class mentorship, strategic guidance, and access to a robust network of investors, providers, payers, manufacturers, and industry experts.
“We are honored to join this year’s MedTech Innovator cohort,” said Melissa Krebs, CEO of GelSana “This opportunity gives us a powerful platform to build key partnerships, engage with investors and accelerate our path to market.”
GelSana was selected based on the unique characteristics of its novel polymers, differentiated from other wound healing solutions due to their ability to reduce inflammation and accelerate healing times for chronic and acute wounds potentially reduce the need for multiple hospital visits as well as amputations. Its value proposition aligns with MTI’s mission to improve patient care through transformative technology.
Throughout the program, cohort companies will present at major industry events including The MedTech Conference powered by AdvaMed (October 5–8 in San Diego) and/or the MedTech Strategist Innovation Summit (November 19–21 in San Diego), where they will compete for a share of $800,000 in non-dilutive funding.
About GelSana
GelSana is developing ground-breaking polymers that offer enhanced wound healing and handling characteristics differentiated from other would dressings available today. GelSana’s patented polymers creates an anti-inflammatory environment, reducing the need for repeated applications and making wound care more efficient and cost-effective. GelSana’s first product, Cleragel™, will be commercially available in 2025. For more information visit GelSanaTherapeutics.com
About MedTech Innovator
MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.
About Innosphere
Innosphere accelerates the success of start-up founders building and commercializing technology and science-based companies, using comprehensive incubation programs, modern office and lab spaces, workforce initiatives, grants, and venture capital, Innosphere is an award-winning 501(c)(3) non-profit organization with a 27-year history of success in its mission to grow the region’s entrepreneurship and innovation ecosystem.
Visit www.innosphere.org to learn more.
For more information contact:
Melissa Krebs CEO
GelSana Therapeutics
[email protected]